Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID:
  • BSEID: 506414
INR
267.65
3.1 (1.17%)
BSENSE

Dec 05

BSE+NSE Vol: 3.56 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
266.49
173.16
139.36
189.92
209.49
187.82
161.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
266.49
173.16
139.36
189.92
209.49
187.82
161.96
Raw Material Cost
60.34
51.10
34.50
76.13
69.89
65.28
50.97
Purchase of Finished goods
32.25
18.18
11.36
11.20
5.10
0.24
0.17
(Increase) / Decrease In Stocks
5.96
-8.97
14.92
-0.18
0.31
-5.59
-10.46
Employee Cost
40.49
31.24
29.06
30.66
33.61
29.01
26.57
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
6.39
0.00
Other Expenses
72.57
62.03
52.50
63.85
59.09
43.20
54.59
Total Expenditure (Excl Depreciation)
211.61
153.58
142.34
181.66
168.01
138.53
121.84
Operating Profit (PBDIT) excl Other Income
54.88
19.58
-2.98
8.26
41.48
49.29
40.12
Other Income
14.20
5.70
3.90
6.53
4.09
2.93
8.10
Operating Profit (PBDIT)
69.08
25.28
0.92
14.79
45.57
52.22
48.22
Interest
5.68
7.12
8.47
9.33
8.55
9.02
9.80
Exceptional Items
0.00
0.00
-7.43
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
63.40
18.16
-14.98
5.46
37.02
43.20
38.42
Depreciation
11.22
12.27
11.88
15.74
12.39
8.91
7.23
Profit Before Tax
52.17
5.89
-26.85
-10.28
24.63
34.29
31.19
Tax
12.54
0.70
0.00
0.70
8.95
5.97
-15.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
39.63
5.19
-26.85
-10.98
15.68
28.31
46.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
39.63
5.19
-26.85
-10.98
15.68
28.31
46.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.08
0.37
0.89
0.62
0.13
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
40.71
5.56
-25.97
-10.36
15.81
28.31
46.74
Equity Capital
14.55
14.50
14.44
14.42
14.42
14.42
4.59
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
13.99
1.92
-8.99
-3.59
5.48
9.82
16.97
Diluted Earnings per share
13.87
1.92
-8.99
-3.59
5.47
9.79
48.45
Operating Profit Margin (Excl OI)
20.59%
11.31%
-2.14%
4.35%
19.8%
26.24%
24.77%
Gross Profit Margin
23.79%
10.49%
-10.75%
2.87%
17.67%
23.0%
23.72%
PAT Margin
14.87%
3.0%
-19.27%
-5.78%
7.48%
15.07%
28.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 53.90% vs 24.25% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 632.19% vs 121.41% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 180.29% vs 757.05% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -20.22% vs -15.94% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Fermenta Biotec. With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
266.49
0
266.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
266.49
0
266.49
Raw Material Cost
60.34
0
60.34
Purchase of Finished goods
32.25
0
32.25
(Increase) / Decrease In Stocks
5.96
0
5.96
Employee Cost
40.49
0
40.49
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
72.57
0.00
72.57
Total Expenditure (Excl Depreciation)
211.61
0
211.61
Operating Profit (PBDIT) excl Other Income
54.88
0.00
54.88
Other Income
14.20
0
14.20
Operating Profit (PBDIT)
69.08
0
69.08
Interest
5.68
0
5.68
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
63.40
0
63.40
Depreciation
11.22
0
11.22
Profit Before Tax
52.17
0
52.17
Tax
12.54
0
12.54
Provisions and contingencies
0.00
0
0.00
Profit After Tax
39.63
0
39.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
39.63
0
39.63
Share in Profit of Associates
0.00
0
0.00
Minority Interest
1.08
0
1.08
Other related items
0.00
0.00
0.00
Consolidated Net Profit
40.71
0
40.71
Equity Capital
14.55
0
14.55
Face Value
5.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
13.99
0
13.99
Diluted Earnings per share
13.87
0
13.87
Operating Profit Margin (Excl OI)
20.59%
0%
0.00
20.59%
Gross Profit Margin
23.79%
0%
0.00
23.79%
PAT Margin
14.87%
0%
0.00
14.87%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 266.49 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 53.90% vs 24.25% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 40.71 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 632.19% vs 121.41% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 54.88 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 180.29% vs 757.05% in Sep 2024

Half Yearly - Interest
Interest 5.68 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -20.22% vs -15.94% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.59%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024